U.S. Sports Medicine Market Outlook

The U.S. sports medicine market is growing steadily as sports injuries, orthopedic procedures, and minimally invasive treatments become more common across hospitals and specialty care centers. According to BIS Research analysis, the market increased from $2,881.5 million in 2020 and is projected to reach $3,856.6 million by 2026, supported by a CAGR of around 4.6% during the forecast period.

The key growth drivers include rising demand for minimally invasive surgical procedures, increasing awareness about the use of implants, and greater adoption of advanced technologies for treating sports-related injuries.

Procedure Volume Is a Key Growth Indicator

Sports medicine procedure volume in the U.S. is also expanding. Total procedures increased from 2.10 million in 2020 and are projected to reach 2.39 million by 2026. This shows consistent demand across both surgical and non-surgical sports injury treatment categories.

Common procedures include shoulder, elbow, hip, and knee arthroscopy, sports-related fracture treatment, joint instability and dislocation management, ligament tear management, cartilage repair, rotator cuff repair, and joint injections.

Schedule a demo to understand how procedure-level intelligence can help identify high-growth opportunities in the U.S. sports medicine market.

High-Volume Sports Medicine Procedures

Several procedures are contributing strongly to market expansion. Rotator cuff repair remains one of the largest procedural categories, growing from 478.42 thousand procedures in 2020 to a projected 574.46 thousand by 2026.

Shoulder arthroscopy is also gaining traction, increasing from 365.60 thousand procedures in 2020 to 418.43 thousand by 2026. Meanwhile, anterior cruciate ligament procedures are projected to rise from 127.25 thousand in 2020 to 137.89 thousand by 2026, reflecting continued demand from athletic and active patient populations.

Regional Trends Across the U.S.

Regionally, the South leads the U.S. sports medicine procedure volume, rising from 869.55 thousand procedures in 2020 to a projected 1.01 million by 2026. The West follows, reaching 608.27 thousand procedures by 2026, while the Midwest and Northeast remain steady contributors.

At the state level, California, Texas, Florida, New York, and Pennsylvania are among the top markets. California is projected to reach 346.31 thousand procedures by 2026, followed by Texas at 254.12 thousand and Florida at 187.37 thousand.

Explore the Surgical Procedure Volume Database to analyze procedure trends by state, region, age group, and specialty.

Age Group Demand and Market Opportunities

In 2020, the 0 to 24 years age group accounted for 64.5% of sports medicine procedural volume, followed by 25 to 64 years at 29.0% and 65+ years at 6.6%. This highlights the role of youth sports participation, athletic injuries, and early orthopedic intervention in shaping market demand.

Going forward, major opportunities are expected in regenerative medicine, implant-based repair, minimally invasive treatment, and data-driven commercial targeting.

To know the projection till 2031, click here and request a quote for deeper forecasts and procedure-level opportunity mapping.

Computed tomography is entering a major technology cycle, comparable to the earlier transition toward multidetector and dual-source systems. In 2026, the competitive question extends beyond how quickly a scanner can acquire an image. The industry is increasingly focused on how much useful information can be extracted from each examination, at what radiation and contrast dose, and with how little operational friction.

BIS Research projects the global computed tomography market to grow from $7,397.4 million in 2025 to $13,197.1 million by 2036, representing a CAGR of 5.47% from 2026 to 2036. Growth is being supported by rising imaging demand, expanding clinical applications, replacement of ageing systems, and investment in advanced detector and software platforms.

Explore the Computed Tomography Market before the next wave of imaging innovation reshapes competitive priorities and investment decisions.

Photon-Counting CT Moves from Breakthrough to Platform Strategy

Photon-counting CT is the most visible structural change in the market. Conventional energy-integrating detectors convert groups of X-ray photons into a combined signal. Photon-counting detectors register individual photons and measure their energy, producing higher spatial resolution, improved spectral information, lower electronic noise, and opportunities to reduce radiation or iodinated contrast exposure.

Clinical evidence is expanding across cardiac, thoracic, neurovascular, abdominal, musculoskeletal, paediatric, and oncological imaging. Research indicates improvements in diagnostic accuracy, reader confidence, image quality, and dose efficiency.

Manufacturers are also broadening their photon-counting portfolios, indicating that the technology is moving beyond a limited premium category and becoming a wider competitive platform. The long-term opportunity will depend on clinical validation, affordability, reimbursement, system availability, and the ability to integrate photon-counting CT into routine diagnostic workflows.

Spectral CT Expands the Value of a Single Examination

Spectral CT is becoming increasingly important in hospital purchasing decisions. By separating X-ray information at different energy levels, spectral systems can support material differentiation, iodine mapping, virtual monoenergetic imaging, and improved characterization of tissues and lesions.

Always-on spectral acquisition is particularly significant because it allows spectral data to become part of routine imaging rather than an additional protocol reserved for complex cases. This can improve first-time-right imaging, reduce repeat examinations, and strengthen diagnostic confidence across emergency, oncology, vascular, and cardiac pathways.

For hospitals, the value of spectral CT will increasingly be measured by its ability to reduce uncertainty, improve lesion characterization, and deliver clinically useful information without adding major workflow complexity.

Download the Complete TOC to see the technologies, market segments, clinical applications, and competitive opportunities covered in the report before making your next strategic decision.

AI Shifts from Reconstruction to Workflow Infrastructure

Artificial intelligence in CT is moving beyond isolated image-processing features. Deep-learning reconstruction can reduce noise, preserve anatomical detail, and support lower-dose protocols. However, the larger opportunity lies in workflow orchestration.

AI is increasingly being applied to patient positioning, protocol selection, acquisition parameters, reconstruction, triage, quantitative analysis, and reporting support. For healthcare providers facing radiologist shortages and rising scan volumes, AI’s commercial value will be measured less by algorithm novelty and more by throughput, consistency, repeat-scan reduction, and time to diagnosis.

The systems that succeed will be those that reduce operational friction across the entire imaging pathway rather than improving only one stage of the examination.

Low-Dose Imaging Becomes a System-Level Requirement

Radiation optimization remains a central design priority because CT uses ionizing radiation. Examinations must be justified and optimized so the required diagnostic information is obtained with the lowest reasonably achievable exposure.

New detector architectures, automated exposure control, iterative reconstruction, and deep-learning reconstruction are making dose reduction increasingly compatible with high image quality. This is particularly relevant for paediatric imaging, lung cancer screening, cardiovascular examinations, and patients requiring repeated follow-up scans.

Low-dose performance is no longer a single product feature. It is becoming a system-level expectation shaped by detector efficiency, software quality, protocol automation, and clinical workflow design.

Request a Sample Report Now to access the market intelligence shaping product strategy, competitive positioning, and investment planning in computed tomography.

What Will Define CT Leadership After 2026?

The next phase of computed tomography will not be defined by one technology. Market leadership will depend on combining advanced detectors, spectral capability, AI reconstruction, automated workflows, service infrastructure, and clinical evidence into scalable imaging platforms.

For manufacturers, the challenge is converting technical performance into measurable clinical and economic outcomes. For hospitals, the priority is selecting systems that improve diagnostic confidence while supporting productivity, interoperability, and long-term upgradeability.

Book a Preview Now!

In 2026, the future of CT is not simply sharper imaging. It is more informative, lower-dose, workflow-aware imaging that supports faster, more precise, and more consistent clinical decisions.

The quantum computing market recorded several commercially significant announcements during the first seven months of 2026. The following developments focus exclusively on what companies are building, acquiring, deploying, or developing through strategic partnerships. Research papers, market forecasts, and developments announced before 2026 have been excluded.

Step Inside the Future of Quantum Computing

1. PsiQuantum and Airbus Target Aerospace Applications

On January 13, PsiQuantum announced a collaboration with Airbus under the QuLAB project. The companies will develop and evaluate fault-tolerant quantum algorithms for complex fluid mechanics problems, including computational challenges associated with aircraft design and aerospace engineering.

See What the Complete Quantum Computing Report Covers

2. Rigetti Secures an $8.4 Million Quantum Computer Order in India

On January 20, Rigetti received an $8.4 million order from India’s Centre for Development of Advanced Computing. Rigetti will deliver a 108-qubit superconducting quantum computer for installation at C-DAC’s Bengaluru supercomputing centre during the second half of 2026.

3. IonQ Agrees to Acquire SkyWater Technology

IonQ announced a definitive agreement on January 26 to acquire semiconductor foundry SkyWater Technology for approximately $1.8 billion. The transaction is designed to give IonQ integrated access to domestic chip fabrication, packaging, prototyping, and advanced manufacturing capabilities.

Get a First Look at the Market Insights- Request a sample report now

4. Atom Computing and Cisco Pursue Distributed Quantum Computing

On March 25, Atom Computing and Cisco signed a memorandum of understanding to explore how neutral-atom quantum computers could be connected through quantum networks. The collaboration addresses the interconnect and networking requirements needed to scale beyond individual quantum processors.

5. Quantinuum and BMW Expand Their Quantum Partnership

Quantinuum and BMW Group expanded their collaboration into a multi-year partnership on May 5. BMW will access future Quantinuum systems while the companies jointly investigate quantum computing applications in advanced materials science, battery technology, mobility, and manufacturing.

6. IBM and the U.S. Government Plan a Quantum Chip Foundry

IBM and the U.S. Department of Commerce announced a letter of intent on May 21 to support a purpose-built American quantum chip foundry. The proposed initiative will support Anderon, a new IBM company focused on expanding domestic quantum-device manufacturing.

7. Microsoft Introduces the Majorana 2 Quantum Chip

Microsoft unveiled Majorana 2 on June 2. According to the company, the next-generation topological quantum chip uses an improved materials stack and contains qubits that are 1,000 times more reliable than those in its previous generation.

8. QuEra and AWS Expand Their Fault-Tolerant Quantum Partnership

On June 15, QuEra announced Libra, its first planned fault-tolerant quantum computer, alongside an expanded multi-year partnership with Amazon Web Services. Libra is expected to become accessible through Amazon Braket in 2028 for commercial, government, and scientific workloads.

9. PsiQuantum Begins Construction of Its Australian Facility

PsiQuantum broke ground on June 18 at Moreton Bay Central in Queensland. The facility is intended to house a utility-scale, fault-tolerant photonic quantum computer supported by semiconductor manufacturing and cryogenic infrastructure.

10. Rolls-Royce Joins a Quantum Computing Partnership for Engine Design

On July 14, Quantinuum, Rolls-Royce, Riverlane, and the University of Edinburgh’s EPCC announced an agreement to examine quantum computing requirements for future industrial workflows. Initial applications include gas-turbine modelling, engine design, and large-scale engineering simulation.

What These Developments Mean for the Quantum Computing Market

Quantum computing activity in 2026 is increasingly centred on manufacturing capacity, industrial applications, fault-tolerant architectures, quantum networking, and commercial infrastructure. Aerospace, automotive, government, cloud computing, and semiconductor companies are becoming direct participants rather than waiting for fully mature quantum systems.

What is an AI-Enabled X-ray Solution and Why Does It Matter?

AI-enabled X-ray solutions integrate artificial intelligence, machine learning, deep learning, and computer vision into conventional radiography workflows to improve image acquisition, analysis, detection, triage, reporting, and clinical decision support. These solutions help automate routine radiology tasks, identify abnormalities, prioritize urgent cases, and support faster diagnostic interpretation.

X-ray imaging remains one of the most widely used first-line diagnostic tools across emergency care, primary diagnosis, trauma assessment, chest imaging, and screening programs. With rising patient volumes and persistent radiology workforce constraints, healthcare providers are adopting AI-enabled X-ray technologies to reduce reporting turnaround times, improve diagnostic consistency, and optimize radiology resources.

According to BIS Research, the global AI-enabled X-ray solutions market was valued at $382.4 million in 2024 and is projected to reach $3,332.5 million by 2036, growing at a CAGR of 19.88% during the forecast period 2026-2036.

Download the complete TOC and Request Sample Report

What’s Driving Growth in the AI-Enabled X-ray Solutions Market?

Key Drivers:

• Growing need for faster triage of urgent chest X-ray findings in emergency and critical care pathways
• Rising imaging volumes across hospitals, outpatient centers, and screening programs
• Persistent shortage of radiologists and increasing demand for workflow automation
• Advancements in deep learning, computer vision, and AI-assisted reporting
• Increasing integration of AI solutions with PACS, RIS, and enterprise imaging systems
• Growing adoption of cloud- and web-based AI platforms for multi-site deployment
• Demand for improved diagnostic consistency, faster turnaround times, and value-based care delivery

What Are the Challenges in the AI-Enabled X-ray Solutions Market?

Key Challenges:

• Human-factor risks, including overreliance on AI outputs and potential clinician deskilling
• False positives that may increase follow-up imaging, referrals, and reporting burden
• Uncertain impact of AI-enabled tools on radiologist workload in real-world settings
• Data privacy and cybersecurity concerns linked to AI-enabled imaging workflows
• Regulatory complexity and need for clinical validation across diverse patient populations
• Interoperability issues with existing hospital IT, PACS, RIS, and non-DICOM systems
• Operational challenges in maintaining balanced human-AI interaction across clinical settings

What is the Recent Development in AI-Enabled X-ray Solutions Market?

March 2026: RadNet, Inc. announced that its subsidiary DeepHealth, Inc. acquired Gleamer to expand its global portfolio of clinical AI solutions across CT, MR, X-ray, mammography, and ultrasound. The acquisition strengthened DeepHealth, Inc.’s AI-powered imaging interpretation and workflow capabilities.

January 2026: FUJIFILM Holdings Corporation introduced a new portfolio of CT, mammography, X-ray, and healthcare IT solutions integrated with AI-enabled medical imaging and workflow automation. The launch aimed to support end-to-end diagnostic workflows, faster clinical decision-making, and improved radiology efficiency across India.

October 2025: Carestream Health Inc. updated its Image Suite V4 Software, MR 11, with AI-enabled image processing features such as bone suppression and pneumothorax visualization. The update was designed to improve diagnostic accuracy, workflow efficiency, and user experience across computed and digital radiography systems.

Market Segmentation: Where Are Growth Opportunities?

By Product

• Hardware
• Software

By Workflow

• Image Acquisition
• Image Analysis
• Detection
• Diagnosis and Treatment Decision Support
• Predictive Analysis and Risk Assessment
• Triage
• Reporting and Communication

By Deployment Model

• Cloud- and Web-Based Solutions
• On-Premise Solutions

By Therapeutic Application

• General Radiology
• Specialty Radiology.

By Region

• North America
o U.S.
o Canada
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Rest-of-Europe
• Asia-Pacific
o China
o Japan
o Australia and New Zealand
o Rest-of-Asia-Pacific
• Rest-of-the-World

Analyst Perspective: What’s Next for AI-Enabled X-ray Solutions?

According to Research Analyst at BIS Research:

“The AI-enabled X-ray solutions market is positioned for significant growth as healthcare systems demand faster, more accurate, and more scalable diagnostic imaging. Rising imaging volumes, radiology workforce constraints, and the shift toward value-based care are increasing the need for AI-enabled tools that can improve clinical decision-making, reduce reporting turnaround times, and strengthen diagnostic consistency. The integration of deep learning, computer vision, PACS, RIS, and enterprise imaging platforms is transforming traditional X-ray imaging into a more intelligent and workflow-centric diagnostic process. With continued investment in research and development, growing adoption of cloud-based deployment models, and increasing use in screening programs and emergency care, the market offers strong opportunities for innovation and global expansion, particularly in emerging and resource-constrained healthcare environments.”

FAQs About the AI-Enabled X-ray Solutions Market

What is the expected growth outlook?

Who are the key leaders in this market?

Which product segment is expected to dominate the market?

Which deployment model is expected to grow strongly?

Where are the major market opportunities?

Want to Make Data-Backed Moves in the AI-Enabled X-ray Solutions Market?

BIS Research provides expert-driven insights, granular segmentation, and strategic advisory across healthcare, medical imaging, AI-enabled diagnostics, and digital health markets.

Request a sample report

Book a Preview

Download the complete TOC